Лив. 52 Лив. 52

INSTRUCTION FOR MEDICAL USE
Liv. 52®
Registration number П N014783/01
Commercial product name
Liv. 52®

PHARMACEUTICAL DOSAGE FORM

Tablets.

PREPARATION FORMULA

Each tablet contains:

Active ingredients:

Powders:

Capparis spinosa auct.non.L.

65,0 mg

Cichorium intybus L.  65,0 mg
Solanum nigrum L. 32,0 mg
Terminalia arjuna (Roxb.)Bedd. 32,0 mg
Cassia occidentalis L. 16,0 mg
Achillea millefolium L. 16,0 mg
Tamarix gallica L.             16,0 mg
Ferrum oxidum 33,0 mg

Which are processed over a steam extract from a mixture of the following herbal raw materials: Eclipta alba Hassk, Phyllanthus amarus Schum.et.Thonn, Boerhaavia diffusa L. , Tinospora cordifolia Miers., Raphanus sativus L., Emblica officinalis Gaertn, Plumbago zeylanica L, Embelia ribes Burm.f., Terminalia chebula Retz., Fumaria officinalis L.

EXCIPIENTS:

Magnesium stearate, microcrystalline cellulose, croscarmellose sodium, carmellose sodium.

DESCRIPTION

Round biconvex tablets of greenish gray color interspersed with lighter and darker color spots.

PHARMACOTHERAPEUTIC GROUP

Hepatoprotective medicicne of plant origin.

ATC Code

[A05BA]

PHARMACOLOGICAL ACTION

A complex of Liv.52® biologically active ingredients of plant origin normalizes the liver protein-synthetic function, stimulates the restoration of liver cells, has a choleretic effect, protects the liver from the effects of toxic substances (alcohol, medicines, etc.), helps to improve the digestion process.

RECOMMENDED INDICATIONS

As a therapeutic and prophylactic agent for:

  • acute hepatitis A;
  • acute and chronic hepatitis B and C;
  • toxic hepatitis, incl. medicinal;
  • anorexia;
  • alcoholic liver disease;
  • precirrotic conditions;
  • in the hepatotoxicity prevention course during the antibiotic intake, anti-tuberculosis, antipyretic agents, contraceptives and other hepatotoxic agents, prevention of anorexia in the course of radiation and chemotherapy.
CONTRAINDICATIONS

Hypersensitivity to the agent components. Cholelithiasis. Child age under 6. Pregnancy and lactation.

The agent is prescribed with caution to patients with acute stomach and intestine diseases.

DOSAGE AND INTAKE METHODS

Peroral 15-30 minutes before meals. As a prophylactic medicine: 2 tablets BID.

As a medicine: children over 6 years old - 1-2 tablets BID/TID; adults - 2-3 tablets BID/TID. Prescription for certain diseases. In acute viral hepatitis A, B or C: children older than 6 years: 1 tablet TID; adults: 2 tablets TID; the therapy course is 2-3 months.

In chronic viral hepatitis B and C: children older than 6 years: 1 tablet TID; adults: 2 tablets TID; the therapy course is 6 months.

In anorexia: children older than 6 years: 1 tablet TID; adults: 2 tablets TID;

The therapy coarse duration is 2 weeks. If necessary, the therapy course can be continued after a 2 week break.

As a hepatoprotective agent in the course of anti-tuberculosis therapy and during the intake of other hepatotoxic drugs, incl. in order to prevent anorexia during the radiation and chemotherapy course: children from 6 years old: 1 tablet BID; adults: 2 tablets BID.

The agent is taken together with anti-tuberculosis and other chemotherapy agents, the duration of the therapy course corresponds to the duration of the chemotherapy course.

In alcohol-related liver disease: 2 tablets TID for 1 month, then 1 tablet TID for 6-12 months.

SIDE EFFECTS

The allergic reactions and dyspeptic disorders are possible;

rarely - loosening in patients with impaired digestion and absorption and/or a history of diarrhea.

INTERACTION WITH OTHER PRODUCTS

Liv.52 reduces the Ibuprofen concentration in blood, possibly due to a absorption slowdown. The agent reduces the bioavailability of tetracycline and doxycycline.

PHARMACEUTICAL FORM

Tablets. 100 tablets in a high density polyethylene plastic vial with a screw cap. The vial neck is additionally tightened with aluminum foil applied by the company's trademark. Each vial with instructions for use is placed in a cardboard box.

RECOMMENDATIONS FOR STORAGE

In a dry place at temperatures from + 10.0 C to + 30.0 C.

Keep out of the reach of children.

EXPIRATION DATE

3 years. Do not use after the expiration date.

DISPENSING RULES

Without recipes.

Name and address of the manufacturing site of the medicinу manufacturer:
Himalaya Drug Co., Makali, Bengaluru 562 162, India.

Name, address of the organization authorized by the holder or owner of the product registration certificate for medical use to accept claims from the consumer/exclusive distributor:
ZAO TRANSATLANTIC INTERNATIONAL, Russia.
119590, Moscow, 1 Olof Palme st.
Tel. (495) 775-39-38; Fax: (495) 514-10-54/67.

ЕАЭС Экологическая марка Употребимо в пищу

Вы собираетесь скачать презентацию о продукте, ее размер

Download the presentation